Evogene Bolsters AI Drug Discovery with Key Scientific Advisory Appointments
Event summary
- Evogene appointed Professors John J. Irwin (UCSF) and Dan T. Major (Bar-Ilan University) to its Scientific Advisory Board (SAB) on February 9, 2026.
- Both appointees are recognized experts in computational chemistry and molecular modeling, with extensive publication records and impactful contributions to the field.
- The appointments are intended to guide the development and refinement of Evogene’s proprietary AI platform, ChemPass AI™.
- ChemPass AI™ is designed to accelerate the discovery and optimization of small molecules for drug development and agricultural chemical innovation.
The big picture
Evogene's move to bolster its scientific leadership underscores the growing reliance on AI and computational chemistry in drug and ag-chemical discovery. The industry is facing increasing pressure to reduce R&D costs and timelines, and AI-driven platforms like ChemPass AI™ represent a potential solution. However, the success of these platforms hinges on the quality of the underlying algorithms and the expertise guiding their development, making the SAB appointments a strategic signal of Evogene's commitment to this approach.
What we're watching
- Technology Validation
- The effectiveness of the SAB’s guidance will be critical in validating ChemPass AI™’s ability to consistently deliver novel and viable drug candidates, and whether the platform can move beyond theoretical potential to demonstrable results in real-world applications.
- Competitive Landscape
- The addition of these prominent researchers may attract increased scrutiny and competition within the AI-driven drug discovery space, potentially accelerating the development of competing platforms and impacting Evogene’s market share.
- Integration Risk
- The successful integration of Prof. Irwin and Prof. Major’s expertise into Evogene’s existing R&D processes will be key; misalignment or friction could hinder the platform's advancement and limit the impact of these appointments.
Related topics